|
Vol.
415, No. 6868 (10 January 2002).
Each year, around 8 million people die from heart attacks and many millions more suffer from, and eventually succumb to, heart diseases such as congestive heart failure and arrhythmia. Global figures are rising, yet calculations suggest that this number could be slashed by around 50 per cent if smoking were removed from the equation. However, decreases would be offset to some degree as the world's population ages, diets become more fat-laden and lifestyles more sedentary, as all these factors are detrimental to a healthy heart. Although scientific study of the heart began four centuries ago, the past few decades have seen a paradigm shift in research. We are now able to monitor the process of contraction and relaxation that underlies the gross function of the heart at close quarters by tracking the movement of calcium and other ions within myocytes. Ultrastructural examination of ion channels is revealing how the regular rhythmic beating of the heart can become disordered. And genetic information is not only uncovering the basis of conditions such as cardiomyopathy in which the heart becomes weak and unable to fulfil its blood circulatory role but is also being exploited with relative success in trials of cardiac gene therapy. Thus, as with all diseases, understanding the processes involved at the molecular and genetic level is enabling us to make inroads in preventing and treating heart disease. Karen Birmingham All of the articles in this Insight are free to registered users of Nature's web site. Registration is a simple process which should take only a few minutes to complete. You can sign up here.
Nature © Macmillan Publishers Ltd 2000 Registered No. 785998 England. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||